anti cancer medicine

Anastrozole Tablets: Oncology Medicine Supplier Medicine Highlights Generic Name: Anastrozole Strength: 1 mg Dosage Form: Film-Coated Tablets Medicine Category: Aromatase Inhibitor Administration: Oral Availability: Prescription Medicine Supply: Bulk Export | Hospital Supply | Distributor Orders Patient Advantages ✔ Once-daily oral treatment ✔ Supports long-term hormone management ✔ Suitable for outpatient therapy ✔ Widely included in breast cancer treatment protocols ✔ Available in export-quality packaging ✔ Bulk quantities available for institutional procurement Before Starting Treatment Patients should inform their healthcare provider if they have: Previous bone fractures or osteoporosis Reduced kidney function Liver disorders High cholesterol levels History of cardiovascular disease Allergic reaction to aromatase inhibitors Regular medical follow-up helps monitor treatment effectiveness and overall health. Possible Undesirable Effects Although not every patient experiences side effects, some may notice: Excessive sweating Difficulty sleeping Muscle discomfort Dryness of the skin Reduced bone mineral density Mood fluctuations Loss of energy Digestive discomfort Frequently Asked Questions Q1. Is Anastrozole used before or after surgery? It may be prescribed before or after surgery depending on the oncologist's treatment strategy. Q2. Can hospitals order Anastrozole in bulk? Yes. Bulk quantities are available for licensed hospitals and pharmaceutical distributors. Q3. Is Anastrozole suitable for long-term treatment? Many patients receive long-term therapy based on their individual treatment plan. Q4. Does this medicine require regular monitoring? Yes. Doctors may monitor bone health, cholesterol, and treatment response during therapy. Q5. Is international export available? Yes. Export supply is available for licensed pharmaceutical importers and healthcare organizations. #Anastrozole1mg #HormoneTherapyMedicine #BreastCancerAwareness #CancerCare #GenericOncology #OncologyExports #PharmaceuticalSupplier #HospitalMedicines #GlobalPharma #CancerTreatment #MedicineWholesaler #HealthcareDistribution #IndianMedicineExporter #BulkPharma #ErnestImpex 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologuymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 Anastrozole Tablets Export from India Buy Generic Anastrozole UK Aromatase Inhibitor Supplier Breast Cancer Drug Distributor Oncology Tablets Manufacturer Hospital Medicine Supplier Pharmaceutical Export Company GMP Cancer Medicine Breast Cancer Hormone Tablets Oncology Medicine Wholesaler International Pharma Export Generic Breast Cancer Medicine Bulk Anastrozole Tablets Licensed Oncology Supplier Anastrozole Procurement Company

Overview of Altretamine Capsules 50mg Altretamine capsules, 50 mg, are specialized oral chemotherapy medications used in the treatment of ovarian cancer, particularly in cases where the disease has returned after initial therapy. Classified as an alkylating agent, this medicine is administered under strict medical supervision as part of a comprehensive cancer care plan. How Altretamine Works Once ingested, Altretamine undergoes metabolic conversion in the body to form active compounds. These compounds disrupt the DNA structure of cancer cells, inhibiting their ability to multiply. By targeting rapidly dividing cells, the medication helps control tumor growth and supports ongoing cancer management. Therapeutic Applications Altretamine capsules are prescribed for the following: Recurrent ovarian cancer cases Advanced-stage ovarian tumors after prior treatments Use alongside other chemotherapy drugs Long-term cancer therapy guided by oncology specialists Administration Guidelines Dosage is customized based on patient-specific factors such as body surface area and overall health. Capsules should be taken orally with water, without crushing or chewing. Adherence to the prescribed schedule is essential for effectiveness. Any changes in dosage should only be made after consulting a healthcare professional. Frequently Asked Questions 1. What conditions are treated with Altretamine Capsules 50mg? It is primarily used for treating ovarian cancer that has recurred after initial chemotherapy. 2. What is the correct way to take this medication? Follow your oncologist’s instructions carefully and take the capsules as prescribed. 3. Can this drug be part of combination therapy? Yes, it may be used alone or alongside other chemotherapy agents depending on the treatment plan. 4. Is international supply available? Yes, it is exported globally to authorized healthcare providers and distributors. 5. Do I need a prescription to obtain Altretamine Capsules? Yes, this medication is strictly available with a valid prescription and requires medical supervision. Administration Guidelines Dosage is customized based on patient-specific factors such as body surface area and overall health. Capsules should be taken orally with water, without crushing or chewing. Adherence to the prescribed schedule is essential for effectiveness. Any changes in dosage should only be made after consulting a healthcare professional. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383 #Altretamine #CancerTherapy #OvarianCancerTreatment #OncologyDrugs #PharmaExports #GlobalMedicineSupply #CancerCareSolutions #GenericPharma #HealthcareDistribution #BulkMedicines #IndianPharmaceuticals #GMPCertified #PharmaIndustry #MedicalExports #Oncology

About Dactinomycin Injection USP 0.5mg Dactinomycin Injection USP 0.5 mg (also known as Actinomycin D) is a prescription chemotherapy medicine used in specialized oncology treatment programs. It belongs to the antitumor antibiotic class and is administered intravenously by trained healthcare professionals. The medicine is commonly incorporated into combination chemotherapy regimens to help control the growth and spread of certain cancers. How Does It Work? Dactinomycin works by attaching to the DNA inside cancer cells, interfering with the production of RNA that is required for cell growth. This action slows or stops the multiplication of rapidly growing cancer cells, allowing oncology treatment protocols to better manage disease progression. Storage Instructions Store according to the manufacturer's recommendations. Protect the vial from excessive heat, moisture, and direct sunlight. Keep the medicine in its original packaging until use. Reconstituted solutions should be handled according to hospital pharmacy protocols. Keep out of reach of unauthorized persons and children. Why International Buyers Choose This Product Reliable oncology medicine for hospital use Suitable for institutional procurement Available for bulk export orders GMP manufacturing options available Export documentation support Consistent pharmaceutical quality standards Suitable for distributors, hospitals and government tenders Buy Dactinomycin Injection USP 0.5mg Online Dactinomycin Injection Exporter Actinomycin D Injection Supplier Dactinomycin Wholesale India Oncology Injection Manufacturer Cancer Medicine Export Company Generic Dactinomycin Supplier Hospital Oncology Drug Distributor Dactinomycin Injection Price Anticancer Injection Export Pharmaceutical Exporter India Oncology Medicines Wholesale Government Tender Oncology Supplier Dactinomycin Bulk Supplier Chemotherapy Injection Manufacturer Frequently Asked Questions (FAQs) 1. What is Dactinomycin Injection used for? It is used in chemotherapy to treat certain types of cancers as part of combination treatment plans. 2. How is Dactinomycin administered? It is given intravenously by trained healthcare professionals in a hospital setting. 3. Can Dactinomycin be purchased online? It is a prescription-only medicine and is supplied to licensed hospitals, distributors, and healthcare institutions. 4. What are the common side effects? Common side effects include nausea, fatigue, hair loss, and reduced blood cell counts. 5. Is Dactinomycin safe during pregnancy? No, it is not recommended during pregnancy due to potential risks to the unborn baby. #Dactinomycin #ActinomycinD #OncologyInjection #CancerMedicines #Chemotherapy #HospitalMedicines #OncologySupplier #MedicineExporter #GenericMedicines #BulkPharma #HospitalProcurement #CancerCare #PharmaceuticalExporter #WHOGMP #GlobalHealthcare #OncologyDistribution #IndianPharma #ErnestImpex 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

About Products Abiraterone Acetate Tablets USP 250 mg are specialized prescription medicines used in the treatment of advanced prostate cancer. This medication works by blocking the CYP17 enzyme, which plays a key role in the production of androgens (male hormones). By reducing androgen levels, abiraterone helps slow the progression of prostate cancer. This therapy is typically administered alongside corticosteroids such as prednisone or prednisolone and should always be taken under the supervision of a qualified healthcare professional. Product Overview Table Product Detail Information Product Name Abiraterone Acetate Tablets USP Strength 250 mg Generic Name Abiraterone Acetate Dosage Form Oral Tablet Therapeutic Category Hormonal Anticancer Therapy Drug Class Androgen Production Inhibitor Route of Administration Oral Standard Pack Options Bottle or blister packs depending on manufacturer Prescription Status Prescription-only medication Supply Category Hospital, wholesale, distributor and export supply Target Locations Bangkok, Thailand and UAE UAE Capital Abu Dhabi Thailand Capital Bangkok Indications Abiraterone acetate is prescribed in combination with prednisone or prednisolone for adult male patients diagnosed with: Metastatic castration-resistant prostate cancer (mCRPC) Metastatic high-risk castration-sensitive prostate cancer (mCSPC) Advanced prostate cancer requiring ongoing hormone suppression therapy Patients are generally advised to continue androgen deprivation therapy using a GnRH analogue unless surgical castration has been performed. Dosing and Administration The standard recommended dosage of abiraterone acetate is: 1,000 mg once daily, which equals four 250 mg tablets, taken together as a single dose. For mCRPC, it is commonly prescribed with prednisone 5 mg twice daily. For mCSPC, prednisone 5 mg once daily may be recommended. The exact dosage and schedule should always be determined by the treating physician. Administration Guidelines Take the medication on an empty stomach. Avoid food for at least two hours before taking the dose. Do not eat for at least one hour after taking the tablets. Swallow tablets whole with water. Do not crush, chew, or break the tablets. Take the medication at the same time each day. Do not alter or stop prednisone without medical advice. FAQs 1. What is Abiraterone Acetate used for? It is used to treat advanced prostate cancer by reducing male hormone production. 2. How should Abiraterone be taken? It should be taken on an empty stomach, once daily, as prescribed by a doctor. 3. Can Abiraterone be taken with food? No, taking it with food can increase side effects due to higher absorption. 4. Is a prescription required for Abiraterone? Yes, it is a prescription-only medication and must be used under medical supervision. 5. Is Abiraterone supplied internationally? Yes, it is available for export to licensed buyers in Thailand, UAE, and other countries. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383 Buy Abiraterone Acetate Tablets USP 250mg online Abiraterone 250mg supplier Thailand Abiraterone tablets distributor Bangkok Abiraterone exporter India Abiraterone 250mg supplier UAE Abiraterone tablets Dubai supplier Abiraterone wholesaler Abu Dhabi Oncology medicine supplier abiraterone Abiraterone bulk supplier Abiraterone 250mg wholesale cost Generic abiraterone exporter Prostate cancer drug supplier Hospital supply abiraterone tablets Abiraterone international exporter WHO-GMP certified oncology supplier Abiraterone tender supplier Abiraterone manufacturer, India Abiraterone bottle supplier #Abiraterone #AbirateroneAcetate #Abiraterone250mg #ProstateCancerTreatment #OncologyDrugs #CancerCareMedicine #PharmaExporter #GlobalMedicineSupply #ThailandHealthcare #BangkokPharma #UAEMedicalSupply #AbuDhabiPharma #DubaiHealthcare #GenericPharmaceuticals #HospitalMedicines #ErnestImpex

Dargen 60mg Injection: Empowering Red Blood Cell Production and Anemia Management Description: Discover Dargen 60mg Injection (Darbepoetin Alfa), a vital medication for treating anemia related to chronic kidney disease and chemotherapy. Learn how Ernest Oncology ensures global access for patients. Dargen 60mg Injection: Advanced Support for Managing Anemia and Boosting Vitality Product Profile: Understanding Dargen 60mg Injection Dargen 60mg Injection features Darbepoetin alfa, an advanced erythropoiesis-stimulating agent (ESA) meticulously engineered to mimic the body's natural hormone, erythropoietin. For individuals struggling with persistent anemia—often a byproduct of chronic kidney disease or the rigorous toll of cancer chemotherapy—this injection serves as a crucial intervention. By signaling the bone marrow to accelerate the production of healthy red blood cells, Dargen helps restore the body’s oxygen-carrying capacity, significantly reducing the reliance on blood transfusions and helping patients regain their strength and daily quality of life. 1. Clinical Indications & Usage Chemotherapy-Induced Anemia: Supporting patients with non-myeloid malignancies who face anemia as a direct side effect of their cancer treatment. Chronic Kidney Disease (CKD) Anemia: Treating patients, both on and off dialysis, whose kidneys are no longer producing sufficient natural erythropoietin. Chronic Kidney Disease (CKD) Anemia: Treating patients, both on and off dialysis, whose kidneys are no longer producing sufficient natural erythropoietin. 2. Mechanism of Action: How Dargen Works Erythropoietin Mimicry: Binds to erythropoietin receptors on erythroid progenitor cells in the bone marrow. Pathway Activation: Initiates the JAK2-STAT5 intracellular signaling cascade to promote cell survival. Red Blood Cell Proliferation: Triggers the maturation and differentiation of progenitor cells into fully functional red blood cells. Sustained Hemoglobin Levels: Its unique molecular structure provides a longer half-life, ensuring consistent support for hemoglobin production over an extended period. 3. Administration and Dosing Guide Administration Routes: It is administered via subcutaneous (under the skin) or intravenous injection. Individualized Dosing: Dosage is strictly determined by your healthcare team based on body weight, current hemoglobin levels, and the underlying condition. Professional Oversight: Treatment should only be conducted by a doctor or nurse in a clinical or hospital setting. Routine Checks: Patients will have regular blood tests to ensure hemoglobin levels remain within a safe and effective range. ⚠️ Safety, Side Effects, and Monitoring Common Reactions: Mild discomfort, redness, or swelling at the injection site, along with potential for headache or abdominal pain. Key Precautions: Use with caution if you have a history of heart disease, seizures, or blood clotting disorders. Blood Pressure Management: Since ESAs can increase blood pressure, your provider will monitor your levels regularly throughout treatment. Warning Signs: Contact a physician immediately if you experience severe headaches, blurred vision, or signs of an allergic reaction (rash, difficulty breathing). 📦 Storage and Handling Specifications Cold Chain Requirement: Must be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Light Sensitivity: Keep the product in its original carton to protect it from exposure to light. Waste Management: Used needles and syringes must be disposed of in a puncture-proof sharps container. 📄 Regulatory and Compliance Documentation Quality Assurance: Every batch adheres to rigorous global manufacturing and pharmacopeial standards. Certified Purity: Shipments include comprehensive Certificates of Analysis (CoA) to verify potency and safety. Stable Logistics: Our medical logistics network maintains precise temperature controls during transit. Compliance Alignment: All distribution processes are aligned with international healthcare procurement and import regulations. WHY CHOOSE ERNEST ONCOLOGY? Global Logistics Expertise Uncompromising Quality Comprehensive Service PRESCRIPTION MEDICINE: YES Disclaimer: This content is for educational purposes and does not replace professional medical advice. Dargen 60mg Injection is a prescription medication. Always consult with a qualified oncologist or healthcare provider regarding treatment plans and medical concerns. 📞 Contact Ernest Oncology — Medicine Exporter (Group of Ernest Pharmaceutical Pvt. Ltd.) Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com Email: exports@ernestpharmaceuticals.com Business Type: Exporter | Bulk Supplier | Distributor WhatsApp: +91 93599 02383 https://wa.me/919359902383

Detailed Guide to Bevatas 400mg (Bevacizumab) Injection: Targeted Therapy & Global Supply In the advanced treatment of multiple malignancies, Bevatas 400mg Injection has become a cornerstone of anti-angiogenic therapy. As a specialized Pharmaceutical Exporter from India, Ernest Oncology (Group of Ernest Pharmaceutical Pvt. Ltd.) ensures that healthcare providers in the USA, UK, UAE, Australia, Singapore, South Africa, and across Asia have seamless access to this high-quality Bevacizumab biosimilar. What is Bevatas 400mg (Bevacizumab)? Bevatas is a biosimilar of the monoclonal antibody Bevacizumab. It is a recombinant humanized monoclonal IgG1 antibody that specifically targets and inhibits the Vascular Endothelial Growth Factor (VEGF). By blocking VEGF, the medication prevents the formation of new blood vessels that tumors need to grow and spread—a process known as anti-angiogenesis. Therapeutic Indications Bevatas 400mg is globally recognized for treating several advanced malignancies: Metastatic Colorectal Cancer: Used in combination with 5-fluorouracil-based chemotherapy. Non-Small Cell Lung Cancer (NSCLC): Specifically for non-squamous, metastatic cases. Glioblastoma: For patients with progressive disease following prior therapy. Metastatic Renal Cell Carcinoma (Kidney Cancer): Used in combination with interferon-alpha. Cervical Cancer: For persistent, recurrent, or metastatic cases. Ovarian Cancer: Including fallopian tube and primary peritoneal cancer. Mechanism of Action Bevacizumab works by neutralizing the biological activity of VEGF: Starving the Tumor: By binding to VEGF, it prevents the protein from interacting with its receptors on the surface of endothelial cells. Vascular Regression: It leads to the regression of existing tumor microvasculature. Inhibiting Neovascularization: It prevents the growth of new blood vessels into the tumor, thereby inhibiting tumor growth. Product Specifications & Clinical Usage Technical Specifications Active Ingredient: Bevacizumab (25 mg/mL) Strength: 400 mg / 16 mL single-dose vial. Form: Sterile, preservative-free, clear to slightly opalescent solution. Manufacturer: Intas Pharmaceuticals Ltd. (Marketed globally via Ernest Oncology). Storage: Strict cold-chain maintenance required at 2°C to 8°C (36°F to 46°F). Do not freeze or shake. Protect from light. Dosage and Administration Method: Administered only by a healthcare professional as an Intravenous (IV) Infusion. It must not be administered as an IV push or bolus. Schedule: Depending on the type of cancer and the treatment regimen, it is typically administered every 2 or 3 weeks. First Infusion: The initial dose is usually delivered over 90 minutes; if well-tolerated, subsequent infusions may be shortened. Safety & Side Effects Common side effects may include: Hypertension (High blood pressure). Fatigue and weakness. Nosebleeds (Epistaxis) and headache. Critical Precaution: Bevacizumab can interfere with wound healing. It is generally recommended to wait at least 28 days following major surgery before starting Bevatas, or to stop the medication at least 28 days before an elective surgery. Why Partner with Ernest Oncology for Global Export? Ernest Oncology specializes in the complex logistics required for high-value oncology biologics like Bevatas 400mg. Validated Cold-Chain: We utilize advanced thermal packaging and data loggers to ensure Bevatas 400mg reaches London, Dubai, or Singapore in perfect condition. Bulk Supplier Advantage: We cater to hospital tenders and pharmacy distributors in South Africa, Australia, and the USA, offering competitive pricing on premium Indian biosimilars. Regulatory Expertise: Our team manages all export documentation (CoA, COO) and international shipping protocols for the Middle East, Africa, and Asia. 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Pomide 4mg Capsule (Pomalidomide): Advanced Immunomodulatory Therapy for Multiple Myeloma Pomide 4mg Capsule is a high-potency anti-cancer medication featuring the active pharmaceutical ingredient Pomalidomide. It is a third-generation immunomodulatory imide drug (IMiD) specifically engineered to treat patients with relapsed or refractory Multiple Myeloma. Manufactured by Cipla Ltd., a global leader in pharmaceuticals, Pomide 4mg offers a vital therapeutic option for patients who have already undergone multiple lines of treatment, providing a targeted approach to inhibiting tumor growth and boosting the body's natural defenses. Therapeutic Indications and Clinical Usage Pomide 4mg is extensively utilized across international oncology protocols for: Relapsed and Refractory Multiple Myeloma (RRMM): Indicated for adult patients who have received at least two prior therapies, including both Lenalidomide and a proteasome inhibitor (such as Bortezomib), and have demonstrated disease progression. Combination Therapy: For maximum clinical efficacy, Pomide is typically administered in combination with low-dose Dexamethasone. Kaposi Sarcoma (KS): In certain regulatory environments, it is also used for adult patients with AIDS-related Kaposi Sarcoma after failure of highly active antiretroviral therapy (HAART). The Mechanism: How Pomide 4mg Works The active molecule, Pomalidomide, exerts its anti-cancer effects through a sophisticated multi-pathway mechanism: Tumor Cell Inhibition: It directly binds to the protein Cereblon, part of an E3 ubiquitin ligase complex. This leads to the degradation of essential transcription factors, triggering apoptosis (programmed cell death) in malignant cells. Immune System Modulation: It enhances the activity of T-cells and Natural Killer (NK) cells, significantly increasing the body's innate ability to identify and destroy cancerous cells. Anti-Angiogenesis: It blocks the formation of new blood vessels that tumors rely on for nourishment and growth, effectively “starving“ the malignant cells. Cytokine Regulation: It inhibits the production of pro-inflammatory cytokines like TNF-$alpha$ and IL-6, which are known to fuel the proliferation of myeloma cells in the bone marrow. Dosage and Administration Guidelines Cycle-Based Dosing: The standard dose is 4 mg orally once daily on Days 1–21 of repeated 28-day cycles. Administration: Capsules must be swallowed whole with water. They should not be opened, crushed, or chewed. Timing: It can be taken with or without food but should be taken at the same time each day to maintain steady therapeutic levels. Renal/Hepatic Adjustment: Dosage adjustments may be necessary for patients with impaired renal or hepatic function, as determined by a specialist. Safety Profile and Side Effect Management Clinical management of Pomide 4 mg requires vigilant professional oversight: Hematological Monitoring: The most frequent side effects include neutropenia (low white blood cell count), anemia, and thrombocytopenia. Regular Complete Blood Counts (CBC) are mandatory. Venous Thromboembolism (VTE): There is a significantly increased risk of blood clots. Patients are often prescribed prophylactic anticoagulants (like aspirin or heparin) concurrently. Embryo-Fetal Toxicity (REMS): Pomalidomide is a known teratogen. Strict adherence to pregnancy prevention programs is mandatory for all patients of reproductive potential. General Effects: Patients may experience fatigue, constipation, diarrhea, or shortness of breath, which are usually managed with supportive care. Storage and Handling Temperature: Store at room temperature, 20°C to 25°C. Security: Keep in the original blister pack to protect from light and moisture. Safety: Caregivers should avoid direct skin contact with the capsules to prevent accidental exposure to the active powder. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

SUNITCAP 12.5 MG Capsule (Sunitinib): Multi-Targeted Tyrosine Kinase Inhibition for Advanced Oncology SUNITCAP 12.5 MG Capsule is a sophisticated oral antineoplastic medication featuring the active pharmaceutical ingredient Sunitinib. As a powerful multi-targeted receptor tyrosine kinase (RTK) inhibitor, it is designed to disrupt the signaling pathways that tumors use to grow, divide, and develop a blood supply. Manufactured under stringent GMP quality standards, SUNITCAP 12.5 MG is a critical therapeutic intervention utilized globally to manage specific solid tumors that have become resistant to standard therapies. Therapeutic Indications and Global Clinical Usage Gastrointestinal Stromal Tumor (GIST): Indicated for the treatment of GIST after disease progression on or intolerance to imatinib mesylate. Advanced Renal Cell Carcinoma (RCC): Used as a primary or secondary treatment for advanced or metastatic kidney cancer. Pancreatic Neuroendocrine Tumors (pNET): Indicated for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease. Mechanism of Action: How SUNITCAP 12.5 MG Works Inhibition of Angiogenesis: It blocks the Vascular Endothelial Growth Factor Receptors (VEGFR), which tumors use to grow new blood vessels to feed themselves. Proliferation Blockade: It targets Platelet-Derived Growth Factor Receptors (PDGFR) and other kinases (like KIT and FLT3), shutting down the “growth signals“ that tell cancer cells to multiply. Dual Action: By simultaneously starving the tumor of its blood supply and stopping cell division, SUNITCAP effectively induces tumor shrinkage and prevents further metastasis. Common Side Effects: Gastrointestinal: Diarrhea, nausea, vomiting, and altered taste (dysgeusia). Dermatological: Skin discoloration (yellowish tint), dry skin, and hand-foot syndrome (redness or swelling of palms/soles). Systemic: Fatigue, high blood pressure (hypertension), and mucosal inflammation. Hematological: Potential decrease in white blood cell or platelet counts. Professional Administration and Safety Protocols Route: Oral administration (capsule). Timing: Can be taken with or without food. Clinical Monitoring: Regular monitoring of blood pressure, heart function (LVEF), and thyroid function is mandatory during treatment. Precise Titration: The 12.5 mg strength is often used in a “4 weeks on, 2 weeks off“ schedule or continuous dosing, depending on the specific cancer type. Storage and Global Handling Instructions Storage: Store at controlled room temperature (20°C to 25°C). Packaging: Keep capsules in the original bottle to protect them from moisture and light. Why Choose Ernest Oncology? 100% Genuine Medication: Sourced directly from GMP-certified channels for maximum efficacy. Verified Global Export Network: We facilitate rapid and secure shipping to the USA, UK, UAE, Australia, Singapore, South Africa, Europe, Middle East, Africa, and Asia. Logistics Precision: Our team manages pharmaceutical exports with expertise, utilizing secure packaging to maintain product stability during transit. Regulatory Support: We handle all necessary export paperwork, including Certificates of Analysis (CoA), for seamless customs clearance. Bulk Supplier Advantage: Competitive wholesale rates to support oncology hospitals, specialized pharmacies, and government health departments. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestimpex.com www.ernestvision.com 📧 Email: [exports@ernestpharmaceuticals.com] 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

HYCALIEVA 2.5 MG Injection (Topotecan): Targeted Topoisomerase I Inhibition for Relapsed Malignancies HYCALIEVA 2.5 MG Injection is a sophisticated antineoplastic agent featuring the active pharmaceutical ingredient Topotecan Hydrochloride. As a semi-synthetic derivative of camptothecin, it serves as a potent inhibitor of the enzyme topoisomerase I. Manufactured under stringent GMP quality standards, HYCALIEVA 2.5 MG is a critical therapeutic intervention utilized globally to manage advanced-stage solid tumors that have shown resistance to primary treatments. Therapeutic Indications and Global Clinical Usage Small Cell Lung Cancer (SCLC): Indicated for the treatment of patients with relapsed SCLC for whom first-line chemotherapy is no longer effective. Advanced Ovarian Cancer: Used as a single-agent therapy for patients with metastatic ovarian carcinoma after the failure of initial or subsequent chemotherapy. Cervical Cancer: Frequently used in combination with cisplatin for the treatment of stage IV-B, recurrent, or persistent carcinoma of the cervix. Pediatric Oncology: Occasionally utilized in specialized research-based protocols for neuroblastoma and other pediatric solid tumors. Mechanism of Action: How HYCALIEVA 2.5 MG Works Enzyme Binding: The drug binds to the topoisomerase I-DNA complex. This enzyme is normally responsible for relieving the torsional strain in DNA by creating reversible single-strand breaks. Complex Stabilization: HYCALIEVA stabilizes these single-strand breaks, preventing the DNA from “re-ligating“ or joining back together. DNA Fragmentation: When the cell attempts to replicate its DNA, the replication fork collides with the stabilized drug-enzyme complex, leading to lethal double-strand DNA breaks. Cellular Apoptosis: The cancer cell is unable to repair this extensive genetic damage, triggering programmed cell death (apoptosis) and halting tumor growth. Common Side Effects: Hematological: Significant bone marrow suppression, including neutropenia (low white blood cells), anemia, and thrombocytopenia. Gastrointestinal: Nausea, vomiting, diarrhea, and stomatitis (mouth sores). General: Fatigue, fever, and generalized weakness (asthenia). Dermatological: Mild hair loss (alopecia) and skin rashes. Professional Administration and Safety Protocols Route: Administered strictly via Intravenous (IV) Infusion. Infusion Schedule: Typically administered daily for 5 consecutive days in a 21-day cycle, though schedules vary by indication. Reconstitution: Must be reconstituted with sterile water for injection and further diluted with 0.9% sodium chloride or 5% Dextrose. Clinical Oversight: Must be administered by specialized oncology teams in settings equipped for real-time monitoring of hematological status. Storage and Global Handling Instructions Storage: Store the un-reconstituted vial at controlled room temperature (20°C to 25°C) and protect from light. Handling: As a hazardous cytotoxic agent, HYCALIEVA 2.5 MG must be handled using appropriate Personal Protective Equipment (PPE) and disposed of according to international biohazard protocols. Why Choose Ernest Oncology? 100% Genuine Medication: Sourced directly from GMP certified channels for maximum safety. Global Distribution Network: Secure and rapid shipping to the USA, UK, UAE, Australia, Singapore, South Africa, Europe, Middle East, Africa, and Asia. Logistics Precision: Our team manages pharmaceutical exports with expertise, utilizing secure packaging to maintain product stability. Regulatory & Documentation Support: We handle all necessary export paperwork, including Certificates of Analysis (CoA), for seamless customs clearance. Bulk Supplier Advantage: Competitive wholesale rates to support oncology hospitals, clinics, and government health programs. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestimpex.com www.ernestvision.com 📧 Email: [exports@ernestpharmaceuticals.com] 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

DACTOLIEVA 0.5 MG Injection (Dactinomycin): High-Potency Cytotoxic Antibiotic for Rare and Pediatric Malignancies DACTOLIEVA 0.5 MG Injection is a highly specialized antineoplastic medication featuring the active pharmaceutical ingredient Dactinomycin (also known as Actinomycin D). Derived from Streptomyces parvullus, this cytotoxic antibiotic is a cornerstone in the treatment of specific rare cancers and pediatric malignancies. Manufactured under stringent GMP quality standards, DACTOLIEVA 0.5 mg is engineered to deliver precise therapeutic intervention for complex oncology cases across the USA, UK, Europe, UAE, and Asia. Therapeutic Indications and Global Clinical Usage Wilms’ Tumor: A primary agent in the management of this pediatric kidney cancer, often used in combination with vincristine. Rhabdomyosarcoma: Utilized in combination regimens for this aggressive soft tissue sarcoma, particularly in children. Ewing's Sarcoma: Integrated into multi-drug protocols for bone and soft tissue tumors. Trophoblastic Neoplasia: Used in the treatment of gestational choriocarcinoma, especially in patients resistant to other therapies. Testicular Cancer: Part of combination cycles for non-seminomatous germ cell tumors. Mechanism of Action: How DACTOLIEVA 0.5 MG Works Intercalation: The Dactinomycin molecule slides between the base pairs (specifically guanine-cytosine) of the DNA double helix. Transcription Blockade: By binding to the DNA, it physically blocks the movement of RNA polymerase, the enzyme responsible for reading DNA. RNA Synthesis Inhibition: This stops the production of messenger RNA (mRNA), which is essential for the cell to create proteins. Cytotoxic Effect: Without the ability to synthesize proteins or replicate its genetic material correctly, the malignant cell ceases to grow and eventually undergoes apoptosis. Common Side Effects Hematological: Anemia, leukopenia (low white blood cells), and thrombocytopenia (low platelets). Gastrointestinal: Nausea, vomiting, loss of appetite, and mouth sores (mucositis). Dermatological: Skin rash, hair loss (alopecia), and “radiation recall“ (skin reactions at previous radiation sites). General: Fatigue, malaise, and potential liver enzyme elevations. Professional Administration and Safety Protocols Route: Administered strictly via intravenous (IV) injection or infusion. Extravasation Risk: This drug is a potent vesicant. Extreme care must be taken to ensure it does not leak into the surrounding tissue, as this can cause severe tissue damage. Precision Dosing: Dosages are frequently calculated based on body surface area ($mg/m^2$) or body weight ($mcg/kg$). Clinical Oversight: Must be administered by specialized oncology teams in settings equipped for the management of cytotoxic toxicities. Storage and Global Handling Instructions Storage: Store the unreconstituted vial at controlled room temperature (20°C to 25°C) and protect from light. Handling: As a hazardous cytotoxic agent, DACTOLIEVA 0.5 MG must be handled using specialized personal protective equipment (PPE) and disposed of according to international biohazard protocols. Why Choose Ernest Oncology? 100% Genuine Medication: Sourced directly from GMP-certified channels for maximum safety. Global Distribution Network: Secure and rapid shipping to the USA, UK, UAE, Australia, Singapore, South Africa, Europe, Middle East, Africa, and Asia. Logistics Precision: Our team manages pharmaceutical exports with expertise, utilizing secure packaging to maintain product stability. Regulatory & Documentation Support: We handle all necessary export paperwork, including Certificates of Analysis (CoA), for seamless customs clearance. Bulk Supplier Advantage: Competitive wholesale rates to support oncology hospitals, pediatric centers, and government health programs. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestimpex.com www.ernestvision.com 📧 Email: [exports@ernestpharmaceuticals.com] 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

IRILIEVA 100 MG Injection (Irinotecan): Advanced Topoisomerase I Inhibitor for Colorectal and Gastrointestinal Malignancies IRILIEVA 100 MG Injection is a potent antineoplastic agent featuring the active pharmaceutical ingredient Irinotecan Hydrochloride. As a derivative of camptothecin, it serves as a semi-synthetic inhibitor of the enzyme topoisomerase I. Manufactured under rigorous GMP quality standards, IRILIEVA 100 MG is a critical therapeutic intervention utilized globally to manage advanced-stage solid tumors, particularly those affecting the gastrointestinal tract. Therapeutic Indications and Global Clinical Usage Metastatic Colorectal Cancer (mCRC): Indicated as a first-line therapy in combination with 5-fluorouracil (5-FU) and leucovorin (the FOLFIRI regimen) or as a single agent for patients whose disease has recurred or progressed following initial fluorouracil-based therapy. Pancreatic Adenocarcinoma: Frequently utilized in combination with other agents (such as in the FOLFIRINOX regimen) for the treatment of metastatic pancreatic cancer. Small Cell Lung Cancer (SCLC): Often employed in specialized treatment lines for patients with extensive-stage lung cancer. Gastroesophageal Malignancies: Used in various systemic protocols for advanced stomach or esophageal cancers. Mechanism of Action: How IRILIEVA 100 MG Works Enzyme Inhibition: The drug binds to the topoisomerase I-DNA complex. This enzyme is responsible for relieving torsional strain in DNA by inducing single-strand breaks. Stabilization of Cleavable Complexes: IRILIEVA prevents the “re-ligation“ (re-joining) of these single-strand breaks. DNA Damage: When the replication fork collides with these stabilized complexes, double-strand DNA breaks are formed. Cellular Apoptosis: Malignant cells are unable to repair these lethal double-strand breaks, leading to irreversible DNA damage and programmed cell death (apoptosis). Professional Administration and Safety Protocols Route: Administered strictly via Intravenous (IV) Infusion. Dilution: Must be diluted in 5% Dextrose Injection (D5W) or 0.9% Sodium Chloride Injection (Normal Saline) before administration. Infusion Time: Standard protocols typically require an infusion duration of 30 to 90 minutes. Clinical Oversight: Must be administered by trained oncology professionals in a setting equipped for the management of acute cholinergic symptoms and delayed diarrhea. Safety Profile and Clinical Monitoring Gastrointestinal Vigilance: Monitoring for “Early Diarrhea“ (cholinergic syndrome) occurring during or shortly after infusion, and “Delayed Diarrhea“ occurring more than 24 hours post-administration. Immediate intervention with loperamide is standard protocol for delayed symptoms. Hematological Monitoring: Regular Complete Blood Counts (CBC) are mandatory to monitor for severe neutropenia and anemia. Hepatic Function: Periodic liver function tests (LFTs) are required, as the drug is primarily metabolized and excreted via the liver and biliary tract. Cholinergic Symptoms: Vigilance for symptoms like sweating, abdominal cramping, and increased salivation, which may require atropine intervention. Storage and Global Handling Instructions Storage: Store at controlled room temperature (20°C to 25°C) and protect from light. Handling: As a hazardous cytotoxic antineoplastic agent, IRILIEVA 100 MG must be prepared and handled using appropriate Personal Protective Equipment (PPE) and disposed of according to international biohazard protocols. Why Choose Ernest Oncology? 100% Genuine Medication: Sourced directly from GMP-certified channels, ensuring every vial is authentic with an optimal shelf life. Global Distribution Network: Secure and rapid shipping to the USA, UK, UAE, Australia, Singapore, South Africa, Europe, Middle East, Africa, and Asia. Logistics Precision: Our team manages pharmaceutical exports with expertise, utilizing secure packaging and efficient transit routes to maintain product stability. Regulatory & Documentation Support: We handle all necessary export paperwork, including Certificates of Analysis (CoA) and permits, for seamless customs clearance. Bulk Supplier Advantage: As a dedicated distributor, we offer competitive wholesale rates to support oncology hospitals, clinics, and government health programs. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestimpex.com www.ernestvision.com 📧 Email: [exports@ernestpharmaceuticals.com] 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

ZODLIEVA 4 mg Injection (Zoledronic Acid): The Gold Standard in Bone Health and Supportive Oncology ZODLIEVA 4 mg Injection is a high-potency bisphosphonate containing the active pharmaceutical ingredient Zoledronic Acid (often referred to as Zoledronate). It is a critical supportive care medication used globally to manage and prevent skeletal-related events in patients with advanced malignancies. By targeting bone metabolism, ZODLIEVA 4mg helps preserve skeletal integrity, reduce bone pain, and manage life-threatening electrolyte imbalances. Therapeutic Indications and Clinical Applications Bone Metastases from Solid Tumors: Indicated for patients with advanced cancers (such as breast, prostate, or lung cancer) that have spread to the bone, helping to prevent fractures and spinal cord compression. Multiple Myeloma: Used to treat bone lesions and prevent skeletal complications in patients diagnosed with plasma cell dyscrasias. Hypercalcemia of Malignancy (HCM): A life-saving intervention used to rapidly reduce and stabilize dangerously high calcium levels in the blood caused by tumor activity. Osteoporosis Management: In certain clinical settings, it is used to increase bone mass and reduce the risk of fractures in high-risk patients. Mechanism of Action: How ZODLIEVA 4mg Works Cytoskeletal Disruption: This blockade disrupts the internal structure of the osteoclast, causing it to lose its ability to resorb bone. Apoptosis: The drug ultimately triggers programmed cell death (apoptosis) in overactive osteoclasts. Mineral Retention: By stopping excessive bone breakdown, ZODLIEVA prevents the release of calcium into the bloodstream and strengthens the bone matrix. Professional Administration and Dosage Route: Administered strictly via Intravenous (IV) Infusion. Infusion Duration: The 4mg dose must be administered over at least 15 minutes. Rapid infusion can significantly increase the risk of renal toxicity. Hydration: Patients must be adequately hydrated before and after administration to protect kidney function. Frequency: For bone metastases, it is typically administered once every 3 to 4 weeks, or as directed by the oncologist. Safety Profile and Clinical Oversight Renal Function: Serum creatinine levels must be checked before every dose. Dosage adjustments are required for patients with mild to moderate renal impairment. Electrolyte Levels: Monitoring of serum calcium, phosphate, and magnesium is essential to prevent hypocalcemia. Oral Health (ONJ): Patients should undergo a dental exam before starting treatment, as bisphosphonates are linked to a rare condition called Osteonecrosis of the Jaw (ONJ). Acute Phase Reaction: Some patients may experience “flu-like“ symptoms (fever, muscle pain, fatigue) within the first three days of the initial infusion. Why Choose Ernest Oncology? 100% Authentic Supply: We source ZODLIEVA directly from GMP-certified facilities, ensuring product integrity and long shelf life. Global Logistics Network: We provide rapid and secure shipping to the USA, UK, UAE, Australia, Singapore, South Africa, Europe, the Middle East, Africa, and Asia. Regulatory Documentation: Every shipment includes the necessary Certificates of Analysis (CoA) and export documentation for hassle-free customs clearance. Wholesale Bulk Supply: We offer competitive pricing models for oncology hospitals, clinics, and government health departments worldwide. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestimpex.com www.ernestvision.com 📧 Email: [exports@ernestpharmaceuticals.com] 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct WhatsApp Connection